Search - tctmd.com

Displaying 241 - 260 of 364

Sort: Relevancy | Date

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

L.A. McKeown

September 13, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

News Daily News

New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides

Michael O'Riordan

August 21, 2019

News Daily News

Genes Bolster Case for Link Between Insomnia and CV Risk

Alison Palkhivala

August 19, 2019

News Daily News

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Yael L. Maxwell

August 14, 2019

News Daily News

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Shelley Wood

July 26, 2019

News Daily News

Higher Risk of Atrial Fibrillation in Retired Football Players

Michael O'Riordan

July 25, 2019

News Conference News SCCT 2019

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Yael L. Maxwell

July 23, 2019

News Conference News SCCT 2019

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Yael L. Maxwell

July 15, 2019

News Conference News SCCT 2019

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Yael L. Maxwell

July 15, 2019

News Daily News

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Yael L. Maxwell

July 04, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

L.A. McKeown

May 13, 2019

News Daily News

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

Yael L. Maxwell

April 24, 2019

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

News Daily News

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Yael L. Maxwell

April 18, 2019

News Conference News

WRAP IT: Novel Antibacterial ‘Envelope’ Reduces Rate of Infections From Implanted Cardiac Devices

L.A. McKeown

March 17, 2019

News Daily News

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Todd Neale

February 18, 2019

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

Advertisement

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides

Genes Bolster Case for Link Between Insomnia and CV Risk

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Higher Risk of Atrial Fibrillation in Retired Football Players

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

WRAP IT: Novel Antibacterial ‘Envelope’ Reduces Rate of Infections From Implanted Cardiac Devices

Atherosclerosis Features Differ Among Male Athletes From Different Sports

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content